Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of convertible loans beginning balance	$ 7,160
Additions	671	$ 5,000
Interest recognized in interest income, net	421	103
Foreign currency remeasurement recognized in other income (expense), net	(162)	176
Unrealized gain (loss) recognized in other comprehensive income (loss)	(942)	1,881
Fair value of convertible loans ending balance	7,148	7,160
Amortized cost basis of Neo Medical Convertible Loans at December 31	$ 6,209	$ 5,279